Relation of laboratory evaluation to clinical effectiveness of antiepileptic drugs.
D000086:Acetazolamide / Q000627:therapeutic use* / Q000633:toxicity; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use* / Q000633:toxicity; D001552:Benzazepines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D004569:Electroencephalography; D004597:Electroshock; D004827:Epilepsy / Q000188:drug therapy*; D005013:Ethosuximide / Q000627:therapeutic use; D006801:Humans; D010433:Pentylenetetrazole; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy*; D014293:Trimethadione / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*
D000927:Anticonvulsants; D001552:Benzazepines; D011324:Primidone; D005013:Ethosuximide; D010672:Phenytoin; D014508:Urea; D000324:Adrenocorticotropic Hormone; D000086:Acetazolamide; D014293:Trimethadione; D010433:Pentylenetetrazole; D010634:Phenobarbital